IBX — Imagion Biosystems Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- AU$2.42m
- AU$9.33m
- AU$1.65m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.433 | 0.501 | 0.243 | 0.57 | 1.65 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 5.88 | 7.96 | 8.87 | 12.7 | 16.7 |
Operating Profit | -5.45 | -7.45 | -8.63 | -12.1 | -15.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.43 | -5.36 | -6.02 | -9.81 | -13.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.43 | -5.36 | -6.02 | -9.81 | -13.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.43 | -5.36 | -6.02 | -9.81 | -13.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.43 | -5.36 | -6.02 | -9.81 | -13.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.375 | -0.281 | -0.23 | -0.35 | -0.4 |
Dividends per Share |